Panacea Biotec has an extensive programme for the development of a package for HIV  treatment with the aim of universal access to treatment for all who need it. Panacea Biotec is developing a range of  Adult and Paediatric anti-retroviral products as per highest quality standards to  achieve pre-qualification by  World Health Organisation (WHO) and for supply to U.N.Agencies for various countries such as Brazil, Countries in Africa etc. across the Global.
The human immunodeficiency virus (HIV) is a retrovirus that infects cells of the human immune system, destroying or impairing their function. In the early stages of infection, the person has no symptoms. However, as the infection progresses, the immune system becomes weaker, and the person becomes more susceptible to so-called opportunistic infections. The most advanced stage of HIV infection is acquired immunodeficiency syndrome (AIDS). It can take 10-15 years for an HIV-infected person to develop AIDS; antiretroviral drugs can slow down the process even further. HIV is transmitted through unprotected sexual intercourse (anal or vaginal), transfusion of contaminated blood, sharing of contaminated needles, and between a mother and her infant during pregnancy, childbirth and breastfeeding.

UNAIDS/WHO 2006 AIDS Epidemic Update estimated 39.5 million people are living with HIV. There were 4.3 million new infections in 2006 with 2.8 million (65%) of these occurring in sub-Saharan Africa and important increases in Eastern Europe and Central Asia, where there are some indications that infection rates have risen by more than 50% since 2004. In 2006, 2.9 million people died of AIDS-related illnesses.